HomeInvestors HealthAscendis raised to outperform by Oppenheimer ahead of drug launch

Ascendis raised to outperform by Oppenheimer ahead of drug launch

525-5250815_gold-ball-free-png-gold-ball-png-clipart

September 5, 2024

Ascendis raised to outperform by Oppenheimer ahead of drug launch

Source link

Previous article

Nio (NIO) Q2 2024 Earnings Call Transcript

Next article

SP500: Blackrock Urges Patience, But It’s “Do-Or-Die” For GenAI (SP500)

Investors Health Image

latest articles

explore more

LEAVE A REPLY Cancel reply

Please enter your comment!

Please enter your name here

You have entered an incorrect email address!

Please enter your email address here